Synthego

Redwood City, United States

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Feb 2022

Series E

Top Investors

RA Capital ManagementMenlo VenturesWellington ManagementFounders Fund8VC

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Synthego's investors?

Synthego's investors include RA Capital Management, Menlo Ventures, Wellington Management, Founders Fund, 8VC.

Where is Synthego headquartered?

Synthego is headquartered in Redwood City, United States.

What does Synthego do?

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

What stage is Synthego at?

Synthego is at the Series E stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 17, 2022.

MLA

"Synthego — Funding & Investors." VCBacked, February 17, 2022, https://www.vcbacked.co/company/synthego. Accessed July 1, 2026.

APA

VCBacked. (2022). Synthego — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/synthego

Wikipedia (cite web)

{{cite web |title=Synthego — Funding & Investors |url=https://www.vcbacked.co/company/synthego |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 17, 2022.